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Centrioles are fundamental and evolutionarily
conserved microtubule-based organelles whose as-
sembly is characterized by microtubule growth rates
that are orders of magnitude slower than those of
cytoplasmic microtubules. Several centriolar pro-
teins can interact with tubulin or microtubules, but
how they ensure the exceptionally slow growth of
centriolar microtubules has remained mysterious.
Here, we bring together crystallographic, biophysi-
cal, and reconstitution assays to demonstrate that
the human centriolar protein CPAP (SAS-4 in worms
and flies) binds and ‘‘caps’’ microtubule plus ends by
associating with a site of b-tubulin engaged in longi-
tudinal tubulin-tubulin interactions. Strikingly, we
uncover that CPAP activity dampens microtubule
growth and stabilizes microtubules by inhibiting
catastrophes and promoting rescues. We further
establish that the capping function of CPAP is impor-
tant to limit growth of centriolar microtubules in cells.
Our results suggest that CPAP acts as amolecular lid
that ensures slow assembly of centriolar microtu-
bules and, thereby, contributes to organelle length
control.
INTRODUCTION
Centrioles are evolutionarily conservedorganelles that arepivotal
for the formation of cilia, flagella, and centrosomes, and are thus
critical for fundamental cellular processes such as signaling, po-
larity, motility, and division (reviewed in Azimzadeh andMarshall,
2010; Bornens, 2012; Jana et al., 2014; Go¨nczy, 2012). Owing to
their central role in such diverse cellular processes, centriole ab-
errations contribute to a range of severe human diseases,
including ciliopathies, primary microcephaly, and cancer (re-
viewed in Nigg and Raff, 2009; Go¨nczy, 2015). Microtubules are
the major constituent of centrioles and are arranged in a radial
nine-fold symmetrical array, typically of triplet microtubules,362 Developmental Cell 37, 362–376, May 23, 2016 ª 2016 The Auth
This is an open access article under the CC BY-NC-ND license (http://which forms a barrel-shaped centriolar wall (reviewed in Azimza-
deh and Marshall, 2010; Bornens, 2012; Jana et al., 2014;
Go¨nczy, 2012). Centriolar microtubules are unique in exhibiting
exceptionally slow growth rates of a few tens of nanometers
per hour on average, and in being very stable after their formation
(Kuriyama and Borisy, 1981; Chretien et al., 1997). Such proper-
ties likely contribute to setting centriole length, which is well
conserved across evolution. The behavior of centriolar microtu-
bules is in stark contrast to that of their cytoplasmic counterparts,
which assemble up to four orders of magnitude faster and are
highly dynamic (Kinoshita et al., 2001). The molecular mecha-
nisms that impart the exceptional slow growth rate and stability
of centriolar microtubules are not known.
Several centriolar proteins that can directly interact with
tubulin and/or microtubules have been identified, including
CEP120, CEP135, Centrobin, and CPAP (Gudi et al., 2011; Lin
et al., 2013a, 2013b; Hsu et al., 2008). CPAP (SAS-4 in worms
and flies) is of particular interest, since it is the only component
among the ones listed above that is present and essential for
centriole formation from worm to man (Kohlmaier et al., 2009;
Schmidt et al., 2009; Tang et al., 2009; Kirkham et al., 2003; Lei-
del and Go¨nczy, 2003). The importance of CPAP is further
substantiated by the fact that homozygous mutations in the
corresponding gene lead to autosomal recessive primary micro-
cephaly, a devastating human disease with drastically reduced
neuron numbers and, thus, brain size (Bond et al., 2005). Inter-
estingly, CPAP overexpression induces overly long centrioles
in human cells (Kohlmaier et al., 2009; Schmidt et al., 2009;
Tang et al., 2009), thus interfering with cell division (Kohlmaier
et al., 2009). Together, these observations suggest that CPAP
somehow regulates centriolar microtubule growth to produce
proper centrioles. How this role is exerted at a mechanistic level
remains elusive.
CPAP comprises a tubulin-binding domain (PN2-3), a posi-
tively charged microtubule-binding domain (MBD), a coiled-coil
dimerization domain, and a C-terminal G box (Figure 1A). The
PN2-3 domain is of prime interest as this region is highly
conserved across evolution and found exclusively in CPAP/
SAS-4 proteins. PN2-3 sequesters tubulin dimers and has
been shown to destabilize microtubules both in vitro and in cells
(Hsu et al., 2008; Cormier et al., 2009; Hung et al., 2004). How
this observation can be reconciled with the presence of overlyors. Published by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Structure of the Tubulin-PN2-3 Complex
(A) Domain organization of human CPAP, with indication of amino acid numbers at domain boundaries. The PN2-3 region is shownmagnified below, with residue
conservation among CPAP/SAS-4 proteins in Homo sapiens, Mus musculus, Gallus gallus, Danio rerio, Xenopus tropicalis, Drosophila melanogaster, and
Caenorhabditis elegans. Black and gray shadings indicate different degrees of residue conservation. Blue and olive bars highlight the LID and SAC domains,
respectively. Asterisks indicate residues that have been mutated in this study. MBD, microtubule-binding domain; CC, coiled coil.
(B) Overall view of the complex formed between PN2-3 (SAC residues in olive), ab-tubulin (gray), and D1 (cyan). The N and C termini of SAC are indicated. The
dashed box depicts the area shown in (C).
(C) Close-up view of the interaction between SAC (olive sticks) and tubulin (gray). Selected secondary structural elements of tubulin are labeled in bold purple
letters. Residues at the tubulin-SAC interface are labeled in black and olive (SAC).
(D) Location of the D1 (cyan), eribulin (brown), and maytansine sites (pink) on b-tubulin. Note that eribulin binds to the vinca site on b-tubulin. The N terminus of
SAC (olive) is shown. The blue oval represents the expected binding region of LID.
See also Tables S1 and S2.long centrioles upon CPAP overexpression, which is suggestive
of the protein-enhancing centriolar microtubule elongation, has
remained puzzling. Here, to elucidate the fundamental mecha-
nism of action of CPAP/SAS-4 proteins, we set out to decipher
how CPAP affects microtubules using structural, biophysical,
and cell biological approaches. We first report a high-resolution
structure of ab-tubulin in complex with the PN2-3 domain of
CPAP. This structural information guided the design of experi-
ments aimed at understanding the key role of CPAP in regulating
centriolar microtubule behavior. Using reconstitution experi-
ments, we demonstrate that CPAP autonomously recognizes
and tracks growing microtubule plus ends. There, CPAP sup-
presses microtubule polymerization and increases microtubule
stability by inhibiting catastrophes and promoting rescues. Wefurther establish that the PN2-3 domain of CPAP is critical in
the cellular context to restrict the extent of centriolar microtubule
elongation by acting as a molecular ‘‘cap.’’
RESULTS
Crystal Structure of the SAC Domain of CPAP in a
Complex with Tubulin
To gain insight into the molecular mechanism of tubulin binding
by CPAP/SAS-4 proteins, we sought to crystallize the PN2-3
domain of human CPAP in complex with tubulin (see Table S1
for all constructs generated in the course of this study). Extensive
crystallization trials with complexes of tubulin and PN2-3
variants were not met with success. However, adding theDevelopmental Cell 37, 362–376, May 23, 2016 363
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Figure 2. Interactions of PN2-3 with Tubulin
and Microtubules
(A–C) ITC analysis of interactions between indi-
cated PN2-3 variants and tubulin. D1, DARPin; Er,
eribulin; Ma, maytansine. Note that eribulin and
maytansine bind to the vinca site and maytansine
site on b-tubulin, respectively (Gigant et al., 2005;
Prota et al., 2014; Smith et al., 2010).
(D) Binding of SAC (olive surface representation)
and LID (schematically represented by a blue oval)
in the context of a microtubule plus end, with
three protofilaments (PF1–PF3) being represented.
Light-gray surface representation, b-tubulin; dark-
gray surface representation, a-tubulin. The plus (+)
and minus () ends of the microtubule are indi-
cated on the right.
See also Figure S1 and Table S1.b-tubulin-binding darpin (D1; Pecqueur et al., 2012) allowed us to
solve the ternary complex formed between PN2-3, ab-tubulin,
and D1 (denoted the D1-tubulin-PN2-3 complex) to 2.2 A˚ resolu-
tion by X-ray crystallography (Figures 1A–1C and Table S2). As
reported previously for other structures, the D1 molecule was
bound at the tip of b-tubulin in the D1-tubulin-PN2-3 complex
structure, a location involved in longitudinal tubulin-tubulin con-
tacts within microtubules (Pecqueur et al., 2012). In addition, we
found electron densities for residues 373–385 of PN2-3, which
correspond to the evolutionarily conserved SAC domain of
CPAP (for ‘‘Similar in SAS-4 and CPAP’’; Leidel and Go¨nczy,
2003; Hsu et al., 2008; Kitagawa et al., 2011) (Figure 1B). In the
PN2-3-tubulin-D1 complex structure, we found that SAC resi-
dues are engaged with both a- and b-tubulin subunits without
affecting the overall conformation of the dimer (root-mean-
square deviation of tubulin in the tubulin-D1 [PDB: 4DRX] and
PN2-3-tubulin-D1 complex structures: 0.49 A˚ over 760 Ca
atoms). The SAC-binding site on tubulin is shaped by hydropho-
bic and polar residues of helices aH110, bH30, bH5, and bH12,
and loops bH8-S7 and bH110-H12 (Figure 1C).
The SAC-tubulin interaction is characterized by an extensive
water and non-water-mediated hydrogen-bonding network, as
well as by hydrophobic contacts established between both
main-chain and side-chain atoms of SAC and tubulin residues.
Prominent SAC side-chain contacts involve Phe375 (bAsp414,
bMet416, bGlu417, bGlu420), Leu376 (bHis192, bQln193,
bGlu196), Lys377 (bGlu420), Arg378 (bGlu420, bAsn426), and
Phe385 (aH406, aTrp407, bPro263). Pull-down experiments
had implicated Lys377 and Arg378 in tubulin binding (Hsu
et al., 2008), and our findings reveal the structural basis for their
importance in this interaction.364 Developmental Cell 37, 362–376, May 23, 2016Atomic Model of the Interaction of
Tubulin and PN2-3
Previous studies suggested that PN2-3
inhibits exchange of the nucleotide on
b-tubulin and that residues situatedN-ter-
minal to SAC also interact with tubulin
(Cormier et al., 2009; Hsu et al., 2008;
Hung et al., 2004). The D1-PN2-3-tubulin
structure revealed that the N terminus of
SAC is located close to the D1-bindingsite at the tip of b-tubulin (Figure 1D). We therefore reasoned
that the presence of D1 might hinder access of this region of
CPAP to its binding site. Accordingly, isothermal titration calo-
rimetry (ITC) experiments demonstrated that whereas PN2-3
bound tubulin with an equilibrium dissociation constant (KD) of
47 ± 6 nM, the affinity of PN2-3 for tubulin-D1 dropped one order
of magnitude (Figure 2A). Likewise, eribulin and maytansine, two
drugs that bind near the D1- and nucleotide-binding site, and
which also inhibit longitudinal tubulin-tubulin contacts in micro-
tubules (Pecqueur et al., 2012; Prota et al., 2014; Alday and Cor-
reia, 2009), significantly impaired the affinity of PN2-3 for tubulin
(Figure 2A). We conclude that the N-terminal part of PN2-3 binds
to a site on the tip of b-tubulin engaged in longitudinal tubulin-
tubulin interactions (Cormier et al., 2009); we therefore named
this putative domain ‘‘LID’’. To test whether the hydrolysis state
of the exchangeable nucleotide bound to b-tubulin is important
for tubulin-PN2-3 complex formation, as previously suggested
for PN2-3 of Drosophila DmSAS-4 (Gopalakrishnan et al.,
2012), we performed additional ITC experiments. As shown in
Figure S1, we found similar KD values for the interaction between
humanCPAPPN2-3 and guanosine diphosphate (GDP)-, guano-
sine triphosphate (GTP)-, or GMPCPP-tubulin (maximal differ-
ence of 1.3-fold). We conclude that the hydrolysis state of the
nucleotide bound to b-tubulin has at most a minor effect on
tubulin-PN2-3 complex formation.
To assess whether SAC and LID can bind tubulin indepen-
dently, we generated two corresponding peptides, SACp and
LIDp, and analyzed their tubulin-binding properties by ITC.
KD values in the low micromolar range were obtained for the in-
teractions between tubulin and either SACp or LIDp (Figure 2B).
To investigate the importance of selected SAC and LID residues
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Figure 3. Effects of CPAPmini on Dynamic Microtubules
(A) Schematic of CPAPmini construct.
(B) Single frame of a time-lapse movie of rhodamine (Rh)-labeled microtubules growing from rhodamine-GMPCPP seeds in the presence of CPAPmini. Arrows
point to CPAPmini microtubule tip accumulation.
(C) Normalized mean intensity profiles for CPAPmini and rhodamine-tubulin obtained from 30 microtubules. Error bars represent SEM.
(D) Kymographs of microtubule growth at the plus (+) andminus () end from a rhodamine-GMPCPP seed with 50 nMmCherry-CAMSAP3 and 100 nMCPAPmini.
(E) Kymographs of microtubule plus-end dynamics with rhodamine-tubulin alone or together with 100 nM CPAPmini.
(F) Kymographs of microtubule plus-end dynamics with 20 nM mCherry-EB3 alone or together with 100 nM CPAPmini.
(G) Kymographs of microtubule plus-end dynamics with rhodamine-tubulin and 100 nM of the two indicated CPAPmini variants.
(legend continued on next page)
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for tubulin binding, we conducted further ITC experiments with
mutant variants of the PN2-3 domain. Mutation of the tubulin-in-
teracting SAC residues Lys377 and Arg378 to glutamic acid
(KR/EE), or of Phe375 and Phe385 to alanine (FF/AA), reduced
the affinity of PN2-3 for tubulin by two orders of magnitude (Fig-
ure 2C; compare with wild-type PN2-3 in Figure 2A). We also
tested a PN2-3 mutant in which three residues in a conserved
region of LID (Phe338, Glu339, Tyr341; Figure 1A) were simulta-
neously mutated to alanine (FEY/AAA), and also in this case
obtained a KD in the low micromolar range (Figure 2C).
These results suggest that both SAC and LID can bind inde-
pendently to tubulin with low micromolar affinities, and that
they cooperate to give rise to a 100-fold tighter interaction
with tubulin when present together. To test whether SAC and
LID could bind in the context of microtubules, we used an atomic
model of a microtubule based on a cryoelectron microscopy
reconstruction at 3.5-A˚ resolution (Zhang et al., 2015). Interest-
ingly, this analysis showed that both SAC and LID binding inter-
faces are located on the outer surface, at the distal tip of the
microtubule, which has exposed b-tubulin subunits (Figure 2D).
This result indicates that CPAP could specifically target microtu-
bule plus ends via its PN2-3 domain.
CPAP Tracks Growing Microtubule Plus Ends In Vitro
To test the idea that CPAP targets microtubule plus ends, we
performed in vitro reconstitution experiments whereby dynamic
microtubules were grown from GMPCPP-stabilized seeds and
imaged using a total internal reflection fluorescence (TIRF) mi-
croscopy-based assay (Bieling et al., 2007;MontenegroGouveia
et al., 2010). Since purified full-length CPAP was insoluble in our
hands, we engineered a soluble chimeric protein in which the
PN2-3-MBD moiety was fused to the leucine zipper domain of
the yeast transcriptional activator GCN4 (O’Shea et al., 1991)
to mimic the dimerization imparted by the endogenous coiled-
coil domain of CPAP (Zhao et al., 2010), which is required for
CPAP function in centriole duplication (Kitagawa et al., 2011),
as well as to GFP (the resulting protein has been dubbed
CPAPmini; Figures 3A and S2A).
We found that CPAPmini bound weakly to the microtubule lat-
tice; importantly, in addition, we found that CPAPmini localized to,
and tracked, one end of dynamic microtubules specifically (Fig-
ures 3B–3E).We determined that CPAPmini bound the plus end of
microtubules, distinguished as such because it is negative for
the minus-end targeting protein CAMSAP3 (Figure 3D) (Jiang
et al., 2014). CPAPmini co-localized at growing microtubule tips
with the plus-end tracking protein EB3 (Figure 3F). However, in
contrast to EB3, the plus-end accumulation of which critically
depends on microtubule growth (Bieling et al., 2007; Mon-
tenegro Gouveia et al., 2010), CPAPmini was enriched at one
end of GMPCPP-stabilized microtubules even when soluble
tubulin was present at a concentration insufficient for microtu-
bule elongation (5 instead of 15 mM tubulin; Figure S2B). These
data reveal that microtubule growth is not required for plus-
end recognition by CPAPmini. In the absence of soluble tubulin,(H–M) Microtubule plus-end growth rate, catastrophe frequency, and rescue fr
mCherry-EB3 and 100 nM of the indicated CPAPmini variants.100–200microtub
condition. Error bars represent SEM.
Scale bars in (D–G) represent 2 mm (horizontal) and 60 s (vertical). See also Figur
366 Developmental Cell 37, 362–376, May 23, 2016CPAPmini localized along the entire length of GMPCPP-stabilized
microtubules (data not shown), indicating that the interaction of
CPAPmini with soluble tubulin suppresses its binding to the
microtubule lattice. Overall, we conclude that CPAPmini is an
autonomous microtubule plus-end tracking protein.
CPAP Promotes Slow and Processive Microtubule
Growth In Vitro
We set out to determine the impact of CPAPmini on microtubule
dynamics. Strikingly, we found that CPAPmini strongly reduced
the rate of microtubule growth (Figures 3E and 3H). This effect
could not be explained by tubulin sequestration, because the
concentration of CPAPmini in these experiments (75–100 nM)
was much lower than that of tubulin (15 mM). Furthermore,
CPAPmini dramatically reduced the frequency of catastrophes
and promoted rescues, together leading to highly processive
microtubule polymerization (Figures 3E, 3I, and 3J). This effect
was also observed in the presence of EB3, despite the fact
that EB3 itself causes a1.5-fold increase inmicrotubule growth
rate and a3-fold increase in catastrophe frequency (Figures 3F
and 3K–3M). To test whether the artificial dimerization domain of
GCN4 in CPAPmini has an influence onmicrotubule dynamics, we
purified a CPAP construct that contains the endogenous coiled
coil (CPAPlong; Figures S2A and S2C). Although CPAPlong had
a higher propensity for degradation and aggregation, it also
bound to microtubule plus ends, very similarly to CPAPmini,
and had a similar effect on microtubule dynamics: it reduced
both the growth rate and the catastrophe frequency, and
increased the rescue frequency (Figures S2D–S2G). These
data demonstrate that GCN4 links CPAPmini polypeptide chains
in a fashion similar to that of the endogenous coiled-coil domain.
Next, we tested the effect of mutations that disrupt either the
tubulin-SAC (KR/EE, FF/AA) or the tubulin-LID interaction
(DLID, FEY/AAA) on the ability of CPAPmini to regulate microtu-
bule plus-end dynamics (Figures 1A and S2A). We found that
all four mutants abrogated tip enrichment, as well as the effects
on microtubule growth and catastrophes (Figures 3G–3L and
S2H). In contrast, all mutants, as well as the dimeric version of
MBD alone (DPN2-3), were still able to bind to the microtubule
lattice and induce rescues to an extent similar to that of wild-
type CPAPmini (Figures 3G–3M). This result suggests that the
MBD has microtubule-stabilizing properties. To further assess
the mechanism underlying the activity of CPAPmini, we investi-
gated how its concentration affects microtubule dynamics. As
mentioned above, at 75 nM of CPAPmini, though not at lower
concentrations, both the microtubule growth rate and the
catastrophe frequency were strongly reduced (Figures 3H–3L,
4A, and 4B). A 4-fold increase in concentration of CPAPmini
had little additional effect on themicrotubule growth rate and ca-
tastrophe frequency, indicating that the effect of CPAPmini on
microtubule elongation in vitro saturates at 75 nM (Figures 4A
and 4B).
We next set out to determine the number of CPAPmini mole-
cules at microtubule plus ends. Single-molecule fluorescenceequency in the presence of rhodamine-tubulin alone or together with 20 nM
ule growth events from two to four independent experiments were analyzed per
e S2 and Table S1.
AB
μm
/m
in 
±
SE
CPAPmini concentration, nM
Microtubule growth rate
0.0
0.2
0.4
0.6
75 100 145 300
D
C
0
0
10
20
30
40
Re
lat
ive
 fr
eq
ue
nc
y %
GFP
CPAPmini
2 4 6 8 10 12 14 16 18 20   x 103
Fluorescence Intensity (a.u)
50 nM 100 nM 300 nM
CPAPmini
0
10
20
30
40
Re
lat
ive
 fr
eq
ue
nc
y %
0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 x 103
Fluorescence Intensity (a.u)
Intensity of CPAPmini molecules
at a microtubule tip
Intensity of single CPAPmini
molecule
50 nM
100 nM
300 nM
0 2 4 6
0
5
10
15
20
Number of CPAPmini molecules at a MT tip
Re
lat
ive
 F
re
qu
en
cy
 %
E
F CPAPmini-GFP CPAPmini-mCherry Rh-tubulin
G
0.0
0.5
1.0
1.5
2.0
Ti
p
La
tti
ce
Dw
ell
 tim
e 
(s)
β
α
+
-
Tubulin
I II
III
MBD
LID
SA
CPN2-3
CC Rescue frequency
Growth rate
Effect on plus ends:
Catastrophe frequency
H
(legend on next page)
Developmental Cell 37, 362–376, May 23, 2016 367
intensity analysis of CPAPmini in comparison with GFP confirmed
that CPAPmini is a dimer (Figure 4C). To determine the number of
CPAPmini molecules at one microtubule tip, we immobilized sin-
gle CPAPmini molecules on the surface of one flow chamber and
performed the in vitro reconstitution assay in the adjacent
chamber on the same coverslip. Images of unbleached CPAPmini
single molecules were acquired first, after which time-lapse im-
aging of the in vitro assaywith CPAPmini was performed using the
same illumination and imaging conditions. We found that
approximately two dimers of CPAPmini were present at microtu-
bule tips in the presence of 100 or 300 nM protein, respectively
(Figures 4D and 4E). Our tubulin-PN2-3 structural model
suggests that CPAPmini, which contains two PN2-3 moieties, in-
teracts with microtubule plus ends by binding to terminal
b-tubulin subunits (Figure 2D). Our reconstitution data thus indi-
cate that CPAPmini can reach its full activity with respect to
microtubule growth inhibition and catastrophe suppression by
binding to approximately four protofilaments.
To acquiremechanistic insights into CPAPmini association with
the microtubule tip and lattice, we mixed 5 nM CPAPmini-GFP
(Figure 4F) with 100 nM CPAPmini-mCherry. This approach al-
lowed us to observe the behavior of single CPAPmini-GFP mole-
cules in conditions whereby the protein inhibits microtubule
growth. Rapid imaging of such samples showed that in most
cases CPAPmini directly associated with the microtubule plus
end, where it remained stationary and then detached. Occasion-
ally, we observed CPAPmini molecules diffusing toward or away
from the microtubule tip (Figure 4F). The analysis of binding
events of CPAPmini at growing microtubule plus ends yielded
an exponential dwell-time distribution with a mean value of
1.7 s (corrected for photobleaching [Helenius et al., 2006]) (Fig-
ures 4G, S3A, and S3B). The dwell time for CPAPmini was longer
than those observed previously for EB1, EB3, and CLIP-170 in
similar conditions (values ranged between0.05 and 0.3 s [Biel-
ing et al., 2008; Montenegro Gouveia et al., 2010]). We also
observed binding and unbinding of CPAPmini to the microtubule
lattice, with an average dwell time of 0.5 s (Figures 4G, S3A,
and S3B). On the lattice, both stationary and mobile CPAPmini
molecules were detected.We noted that a single CPAPmini mole-
cule could switch between the two types of behavior (Figure 4F).Figure 4. Counting of CPAPmini Molecules at Microtubule Plus Ends
(A) Kymographs illustrating growth dynamics of microtubule plus ends in the prese
CPAPmini channel is shown. Scale bars represent 2 mm (horizontal) and 60 s (ver
(B) Microtubule growth rates at indicated concentrations of CPAPmini in the pres
(C) Distribution of fluorescence intensities for singlemolecules of GFP (blue, mean
6.2 3 103 ± 3.1 3 103). Mean intensity values are reported as means ± SD.
(D) Distribution of fluorescence intensity values for single immobilized CPAPmini
CPAPmini (100 nM) molecules at microtubule tips (red, mean intensity value 15.2
(E) Distributions of the numbers of CPAPmini molecules on microtubule plus ends
sufficient to strongly suppress microtubule growth, 2 CPAPmini dimers were bo
(F) Kymographs of dynamic microtubules grown in the presence of 100 nM CP
CPAPmini single-molecule behavior at the tip and lattice. Plus ends are indicated b
and tip tracking, while molecules displaying stationary behavior at the microtubul
2 s (vertical).
(G) Mean dwell times for CPAPmini on the microtubule lattice (mean time = 0.51 ± 0
time distributions; reported means were corrected for photobleaching. Error bar
(H) Working model of how CPAPmini ensures slow processive microtubule growth
andMBDdomains (I). This stabilizes the interaction of the terminal tubulin dimers, ‘
‘‘Opening’’ of LID (dashed curved arrow), spontaneously and/or induced by an in
See also Figure S3 and Table S3.
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squared displacement (MSD) analysis indicated that the mobile
CPAPmini molecule population undergoes one-dimensional diffu-
sion, as the increase of the MSD value over time was linear
(Figures S3C–S3E) (Qian et al., 1991). The diffusion coefficient
of CPAPmini bound to microtubule lattices was 0.03 ±
0.0004 mm2 s1 (Table S3). This value is three times lower than
that for EB3 and similar to the one for the kinesin-13 MCAK,
obtained under similar conditions (Montenegro Gouveia et al.,
2010).
Taken together, these results demonstrate that CPAPmini local-
izes to microtubule plus ends mostly through direct binding and
remains largely immobile at themicrotubule tip until detachment.
This behavior, aswell as the longer dwell times at themicrotubule
plus end comparedwith the lattice, can be explained by the pres-
ence of the LID domain, which can attach CPAPmini to the tip of a
protofilament. Our data further show that CPAPmini can either
diffuse along the lattice or bind to it in a stationary manner. We
think that these two types of CPAPmini behavior might be due to
the presence of the MBD and SAC domains, which can indepen-
dently interact with microtubule lattices. Finally, our results
demonstrate that CPAPmini suppresses microtubule growth and
stabilizesmicrotubules by inhibiting catastrophes and promoting
rescues. In combination with the structural and biophysical data,
our reconstitution data suggest that CPAPmini ensures slowproc-
essive microtubule growth by capping and stabilizing the plus
ends of protofilaments (Figure 4H).
Both the SAC and MBD Domains of CPAP Are Essential
for Centriole Assembly
Our in vitro observations raised the possibility that CPAP could
contribute to centriole formation in two ways: the MBD could
promote centriolar microtubule assembly by stabilizing microtu-
bules, while LID, together with SAC, might limit centriolar micro-
tubule elongation by slowing growth of their plus ends. To test
these predictions in the cellular context, we generated cell lines
conditionally expressing YFP-tagged CPAP transgenes resistant
to RNAi targeting endogenous CPAP (Kitagawa et al., 2011). We
analyzed mitotic cells using the centriolar marker Centrin 2 as a
readout of successful centriole assembly. Whereas >90% ofnce of 20 nMmCherry-EB3 and indicated concentrations of CPAPmini. Only the
tical).
ence of 20 nM mCherry-EB3. Error bars represent SEM.
intensity value 3.43 103 ± 1.63 103) and CPAPmini (green, mean intensity value
molecules (green, mean intensity value = 8.3 3 103 ± 3.2 3 103) compared to
3 103 ± 4.7 3 103). Mean intensity values are reported as means ± SD.
at indicated protein concentrations of CPAPmini. At 100 nM, a concentration
und to microtubule tips (green curve).
APmini-mCherry, 5 nM CPAPmini-GFP, and rhodamine-tubulin, demonstrating
y black arrows. White arrows point to examples showing both lattice diffusion
e tips are indicated by arrowheads. Scale bars represent 2 mm (horizontal) and
.01, n = 258) and tip (mean time = 1.67 ± 0.06, n = 755) obtained from the dwell-
s represent the error of fit (see Supplemental Experimental Procedures).
. CPAP recognizes the microtubule plus end via tandemly arranged LID, SAC,
‘caps’’ the corresponding protofilaments, and stabilizes themicrotubule lattice.
coming tubulin dimer (II), enables processive microtubule tip elongation (III).
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control cells containedR4 centrioles, this was the case for fewer
than 10% of cells depleted of endogenous CPAP (Figures 5A,
5B, 5I, and S4A) (Kohlmaier et al., 2009; Schmidt et al., 2009;
Tang et al., 2009). YFP-CPAP rescued this phenotype to a large
extent, with >80% of cells having successfully duplicated their
centrioles (Figures 5C, 5I, and S4A) (Kohlmaier et al., 2009;
Schmidt et al., 2009; Tang et al., 2009). Strikingly, we found
that the removal of MBD (DMBD) completely abolished centriole
assembly, to levels that are even lower than depletion of CPAP
alone, likely due to dominant-negative effects following heterodi-
merization of YFP-CPAP-DMBD with any residual endogenous
CPAP (Figures 5D, 5I, and S4A). We conclude that the microtu-
bule-stabilizing effect of MBD observed in vitro is essential for
centriole biogenesis.
We found also that CPAP constructs lacking the LID domain or
with key residues mutated, YFP-CPAP-DLID and FEY/AAA,
respectively, were able to sustain centriole assembly in 65%
of cells (Figures 5G–5I), indicating that LID contributes to, but is
not essential for, this process. In contrast, CPAP function was
severely compromised upon mutation of SAC (KR/EE or FF/AA;
Figures 5E, 5F, and 5I), in line with previous findings (Hsu et al.,
2008; Kitagawa et al., 2011; Tang et al., 2009). Impaired function
of all CPAP mutants likely reflects an impact on protein activity,
because localization and turnover at the centrosome were unaf-
fected (Figures 5C–5H and S4B). Overall, these results establish
that MBD and SAC are critical for centriole assembly, whereas
LID appears to play an accessory role in this process.
CPAP Regulates the Length of Centriolar Microtubules
in Cells
We further investigated the function of SAC and LID by analyzing
cells depleted of endogenous CPAP and overexpressing YFP-
CPAP variants, which provided us with an assay system to
address the contribution of distinct domains of CPAP to centriole
biogenesis. In these conditions, wild-type YFP-CPAP leads to
the formation of overly long centrioles that contain not only
CPAP but also other centriolar markers such as Centrin 2 along
their entire length (Figures 6A and 6D), as reported for cells over-
expressing wild-type CPAP in addition to having the endoge-
nous protein (Kohlmaier et al., 2009; Schmidt et al., 2009; Tang
et al., 2009). In contrast, we found no overly long centrioles
upon YFP-CPAP-DMBD overexpression (Figures S4C and
S4D), as anticipated from the fact that MBD is essential for
centriole assembly. Mutation of SAC (KR/EE or FF/AA) led to a
reduction in the proportion of cells with overly long centrioles
while deletion of LID had no such effect, again reflecting the
respective impact of these variants on the ability of CPAP to sus-
tain regular centriole assembly (Figures 6A, 6D, S4C, and S4D).
Intriguingly, close examination of cells depleted of endoge-
nous CPAP and overexpressing either YFP-CPAP-FF/AA orFigure 5. Effect of PN2-3 Mutations on CPAP Cellular Function
(A–H) Mitotic U2OS FlpIn TREX cell lines without transgene (A and B) or express
siRNA targeting endogenous CPAP (B–H), stained with antibodies against Centrin
and represent 10 mm in main image and 1 mm in insets.
(I) Percentage of cells showing successful centriole duplication (R4 Centrin 2 fo
dividual values for each experiment. n > 100 cells analyzed for each condition an
each CPAP mutant to the wild type transgene, with the p values < 0.05 for all sa
See also Figure S4 and Table S1.
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tive fibers that stemmed from centrosomes, but which did not
contain centriolar markers along their length (Figures 6A and
6C). To determine whether such centrosomal fibers originated
from centrioles or from the pericentriolar matrix, we conducted
immunofluorescence experiments with a marker surrounding
the proximal end of parental centrioles (CEP63) and onemarking
the distal end of all centrioles (Centrin 2). This analysis revealed
that 80% of centrosomal fibers appeared to be continuations
of the distal end of regular centrioles or of overly long centrioles,
and were thus termed centriole fibers (Figures 6E and 6F). These
fibers, lackingCentrin,wereoftenconsiderably longer thanoverly
long centrioles bearing Centrin (Figure 6H) and were positive for
a-tubulin (Figures 6I and 6J), raising the possibility that they
correspond to abnormal extensions of centriolar microtubules.
To test this hypothesis, we carried out correlative light and
electron microscopy (CLEM; Figures 7 and S5). In line with pre-
vious observations (Kohlmaier et al., 2009; Schmidt et al., 2009;
Tang et al., 2009), we found that cells overexpressing YFP-CPAP
and depleted of endogenous CPAP harbored overly long centri-
oles, in which microtubules extended from the distal end of the
centriole (Figures 7B and 7F; compare with 7A and 7E). Strik-
ingly, cells expressing YFP-CPAP-DLID also exhibited microtu-
bule extensions from the distal end of the centriole, which
attained several microns in some cases (Figures 7C and 7G).
To ensure that such figures represented centriole fibers (i.e.,
devoid of Centrin) and not overly long centrioles (i.e., bearing
Centrin), we carried out further CLEM experiments using
tagRFP-Centrin 1 as an additional marker. In agreement with
our immunofluorescence analysis, we found that YFP-CPAP-
DLID centriole fibers were indeed microtubules extending from
the distal end of centrioles (Figures 7D and 7H). We conclude
that the activities of LID and SAC can prevent aberrant overex-
tension of centriolar microtubules.
DISCUSSION
Our study provides fundamental insights into themechanisms by
which the evolutionarily conserved family of CPAP/SAS-4 pro-
teins regulate the growth of centriolarmicrotubules, thus contrib-
uting to setting organelle size. Whereas the crystal structure of
the G box of CPAP, either alone or in complex with a peptide
derived from the centriolar protein STIL, has been solved (Zheng
et al., 2014; Cottee et al., 2013; Hatzopoulos et al., 2013), high-
resolution structural information on the evolutionarily conserved
domains interacting with tubulin and microtubules was lacking,
precluding full understanding of how CPAP regulates centriole
biogenesis. The structural and biophysical data presented here
reveal a dual binding mode between tubulin and the LID plus
SAC domains of PN2-3, explaining its tubulin-sequestering anding the indicated YFP-CPAP variants (C–H), treated with control siRNA (A) or
2 (magenta) and GFP (green); DNA in blue. Scale bars in (A) apply to all images
ci). Bars show the mean of three experimental repeats; circles indicate the in-
d per experiment. Two-tailed unequal variance t-tests were used to compare
mples except FEY/AAA (p = 0.0784). Full dataset is shown in Figure S4A.
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Figure 7. Centriole Fibers Are Centriolar Microtubule Extensions
(A–H) CLEM of cells expressing tagRFP-Centrin 1 (Cell 1; A, E), YFP-CPAP and tagRFP-Centrin 1 (Cell 2; B, F), YFP-DLID (Cell 3; C, G), or YFP-DLID plus tagRFP-
Centrin-1 (Cell 4; D, H), and simultaneously depleted of endogenousCPAP using RNAi (Cells 2–4). (A–D) Fluorescencemicroscopy images of the region of interest
in each cell. Scale bar, 1 mm. (E–H) Corresponding high-magnification electronmicrographs of the boxed region in (A–D), showing one 50 nm section from a serial
section series. Yellow arrowheads indicate microtubule extensions from the distal ends of centrioles. Scale bars, 500 nm. Ten cells expressing YFP-DLID were
analyzed, which contained a total of 28 centrioles. Of these, three were centrioles with an apparent normal length and structure, two were overly long centrioles
without further microtubule extensions, four exhibited PCM fibers, whereas 19 harbored microtubule extensions from their distal ends (as illustrated in G and H).
Of these 19 centrioles, six came from the experiment where cells were also expressing tagRFP-Centrin 1 and could therefore be unambiguously classified as
centriole fibers (i.e., without tagRFP-Centrin 1 signal) rather than overly long centrioles.
See also Figures S5 and S6.microtubule-destabilizing activities (Hsu et al., 2008; Cormier
et al., 2009; Hung et al., 2004). The finding that LID binds at
the tip of b-tubulin, in combination with the structural model
suggesting that PN2-3 can bind the terminal b-tubulin subunits
on the outside of a microtubule, strongly suggested that PN2-3
represents an autonomous microtubule plus-end targeting
domain in CPAP.Figure 6. Fibers Extend from Centrioles upon Expression of CPAP Lac
(A–D) U2OS cells expressing indicated YFP-CPAP variants and depleted of endog
GFP (green). (A) Quantification of the YFP structures illustrated in (B–D) (n > 100 p
cells contain multiple types of structure. Scale bar, 1 mm.
(E–G) Proportion of YFP-CPAP-DLID expressing cells with centriole fibers (E and F
17, and 26 cells, respectively. Scale bar, 1 mm.
(H) Length of overly long centrioles and of centriole fibers in the indicated cond
respectively. Bars indicate the mean, squares indicate the minimum and maxim
unequal variance t test comparing DLID overly long centrioles and centriole fiber
(I and J) YFP-CPAP-DLID cells without (I) or with (J) 1 hr incubation on ice s
centriole protein POC5 (magenta). Arrowheads indicate end of centrioles from wh
YFP-CPAP-DLID along the centriole fiber becomes sparser following ice-induced
5 mm (inset).
372 Developmental Cell 37, 362–376, May 23, 2016To test whether this is the case, we performed dynamic micro-
tubule reconstitution experiments and indeed found that the
sequential arrangement of LID, SAC, and MBD in a dimeric
configuration localizes CPAPmini to growing microtubule plus
ends. The plus-end localization of CPAPmini is unlikely to depend
on co-polymerization with tubulin, because tip localization is
observed at CPAPmini concentrations that are several orders ofking the LID Domain
enous CPAP by RNAi, stained with antibodies against Centrin 2 (magenta) and
er sample). Note that the total exceeds 100% here and in (E–G) because some
) or PCM fibers (G). Percentages are themean of three experiments ± SD; n = 9,
itions determined using GFP immunofluorescence. n = 42, 22, and 37 cells,
um values, and error bars indicate the SD. Student’s two-sample two-tailed
s with CPAP-induced overly long centrioles: ***p < 0.001; n.s., not significant.
tained with antibodies against a-tubulin (gray), GFP (green), and the distal
ich emanate fibers, as determined by the POC5 signal. Note that the signal of
microtubule depolymerization. Scale bars represent 10 mm (main image) and
magnitude lower than that of tubulin. Analysis of the behavior of
single CPAPmini molecules in our in vitro reconstitution system
showed that the majority of CPAPmini molecules bound to
microtubule plus ends directly. CPAPmini also displayed one-
dimensional diffusion along the microtubule lattice, as described
previously for other microtubule-end-interacting proteins (Brou-
hard et al., 2008; Bieling et al., 2008; Helenius et al., 2006;
Montenegro Gouveia et al., 2010); however, diffusion did not
seem to be a major contributing factor responsible for the
recruitment of CPAPmini to microtubule plus ends. Notably, in
the context of a centriole, CPAP is expected to be organized in
a precise manner along the inside of the centriole wall where it
binds STIL, and is thus very likely not diffusive (Hatzopoulos
et al., 2013).
Our reconstitution data revealed that depending on the condi-
tions, microtubule-tip-localized CPAPmini slows down microtu-
bule growth 5- to 8-fold and that only a few CPAPmini molecules
suffice to induce this effect. Based on the structural and biophys-
ical results, we propose that the LID and SAC domains of
CPAPmini bind terminal b-tubulin subunits exposed at the micro-
tubule plus ends and thereby occlude the binding sites for the
incoming tubulin dimers. The ability of PN2-3 to block longitudi-
nal tubulin-tubulin interactions is reminiscent of the tubulin-
sequestering protein stathmin and the microtubule plus-end
capping ligands DARPin D1, eribulin, and maytansine (Gigant
et al., 2000; Pecqueur et al., 2012; Smith et al., 2010; Prota
et al., 2014). However, in striking contrast to these micro-
tubule-destabilizing and polymerization-blocking agents,
CPAPmini stabilizes microtubules by potently suppressing catas-
trophes and promoting rescues. The latter property can be
attributed to the MBD, which binds strongly to the microtubule
lattice and can autonomously induce rescues. The MBD is
positively charged, and its binding to negatively charged micro-
tubules likely involves an electrostatic mechanism, similar to that
of microtubule lattice-binding regions of cytoplasmic microtu-
bule regulators such as XMAP215/ch-TOG (Brouhard et al.,
2008; Widlund et al., 2011). We assume that the MBD of
CPAPmini binds along, as well as between, protofilaments to sta-
bilize microtubules.
Based on these considerations, we conclude that this partic-
ular mode of binding to microtubule plus ends, due to the com-
bination of LID, SAC, and MBD, can ‘‘cap’’ and stabilize terminal
tubulin dimers (Figure 4H). We postulate that in this state, a cap-
ped protofilament can only be elongated by an incoming tubulin
dimer if the LID domain is released and frees the interaction site
needed for establishing longitudinal tubulin-tubulin contacts.
The release of LID in turn weakens the CPAPmini microtubule
plus-end interaction and either promotes CPAPmini detachment
or enables the liberated PN2-3 domain to cap the newly elon-
gated protofilament or a neighboring one. Notably, slowing
microtubule growth normally promotes catastrophes by
reducing the size of the GTP cap (Walker et al., 1988; Janson
et al., 2003). Accordingly, microtubule polymerization suppres-
sors typically act as microtubule depolymerases. However, ex-
ceptions to this rule are known, including the kinesin-4 family
members Xklp1/KIF4 and KIF21A which, similarly to CPAPmini,
can suppress both microtubule growth and catastrophes (Bring-
mann et al., 2004; Bieling et al., 2010; Van der Vaart et al., 2013).
The molecular basis of kinesin-4-mediated microtubule growthinhibition is not understood, but is very likely distinct from that
of CPAPmini, because both Xklp1/KIF4 and KIF21A aremolecular
motors that can move along microtubules and accumulate at
microtubule plus ends due to their processive motility (Bieling
et al., 2010; Van der Vaart et al., 2013). In contrast, CPAP pre-
sents a unique arrangement of tubulin-binding and microtu-
bule-lattice-binding domains, which together have the potential
to recognize, cap, and stabilize microtubule plus ends, a mech-
anism that to our knowledge has not been previously described
for any microtubule regulator.
In cells, centriolar microtubules grow very slowly and proces-
sively as judged from the analysis of specimens prepared from
different stages of the cell cycle (Kuriyama and Borisy, 1981;
Chretien et al., 1997). However, the mechanisms underlying
such slow and regulated elongation have remained elusive.
Our study reveals that CPAP plays a critical dual role in ensuring
that this is the case. First, our data indicate that a pivotal function
of CPAP is to stabilize centriolar microtubules via its MBD, which
likely explains why this domain is essential for centriole assem-
bly. Second, although the capacity of LID to cap microtubule
plus ends is not essential for this stabilization function, and
thus for centriole formation, it exerts a negative role by limiting
microtubule extension from the distal end of centrioles. The
SAC domain, which interacts with the lateral side of tubulin di-
mers, can contribute to both microtubule stabilization and
capping functions, potentially explaining why mutations in SAC
affect centriole formation more strongly than those in LID. These
considerations can at least partially explain why centrioles over-
elongate when CPAP dosage is increased (Kohlmaier et al.,
2009; Schmidt et al., 2009; Tang et al., 2009); however, addi-
tional mechanisms likely control the activity of CPAP domains
in cells. Our in vitro data revealed that approximately two
CPAPmini dimers are sufficient to limit the growth rate of a single
microtubule, suggesting that CPAP works at substoichiometric
levels. In the context of the centriolar microtubule wall, we
expect approximately two CPAP dimers to be able to access
the microtubule tips of each triplet from the luminal side of the
centriole (Figure S6) (Hatzopoulos et al., 2013; Sonnen et al.,
2012; Tang et al., 2011).
Overall, our results reveal that CPAP is a highly specialized
microtubule plus-end regulator that acts as a molecular cap to
ensure slow and processive growth of centriolar microtubules.
Given that endogenous CPAP is present primarily in the proximal
region of mature centrioles (Kohlmaier et al., 2009; Schmidt
et al., 2009; Tang et al., 2009), we propose that CPAP activity
is most critical during the early stages of centriole elongation.
Upon overexpression of the wild-type protein, excess CPAP
molecules localize along the entire length of centrioles and could
cause overelongation of centriolar microtubules due to the
microtubule stabilization activity of ectopic CPAP. Furthermore,
we speculate that upon overexpression of a mutant protein lack-
ing LID-domain function, overelongation of centriolar micro-
tubules is exacerbated due to the lack of capping function
(Figure S6).
We note that microtubule growth rates obtained in vitro upon
CPAPmini addition are still some three orders of magnitude faster
than those estimated for centriolar microtubules in cells (Kur-
iyama and Borisy, 1981; Chretien et al., 1997). Regions of
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including the G box, that may organize CPAP molecules along
the entire length of themicrotubule wall in a precisemanner (Hat-
zopoulos et al., 2013), as well as post-translational modifica-
tions, could be important to further bolster CPAP activity; these
features are not recapitulated by the CPAPmini and CPAPlong
constructs used in our study. In addition, other centriolar pro-
teins have been implicated in controlling centriole length,
including the CPAP-interacting proteins CEP120, CEP135, and
Centrobin (Gudi et al., 2011; Lin et al., 2013a, 2013b). It will be
of prime interest to assess on amechanistic level how these pro-
teins cooperate to impact on CPAP function or otherwise
contribute to regulate organelle size.
EXPERIMENTAL PROCEDURES
Protein/Peptide Preparation and Isothermal Titration Calorimetry
Standard protein production in bacteria and peptide synthesis is described in
Supplemental Experimental Procedures. ITC experiments were performed at
25C using an ITC200 system (Microcal). Proteins were buffer-exchanged to
BRB80 (80 mM PIPES-KOH [pH 6.8] supplemented with 1 mM MgCl2
and 1 mM EGTA) supplemented with 0.5 mM tris(2-carboxyethyl)phosphine.
0.1–0.4 mM PN2-3 variants in the syringe were injected stepwise into
10–20 mM tubulin solutions in the cell. The resulting heats were integrated
and fitted in Origin (OriginLab) using the standard ‘‘one set of sites’’ model pro-
vided by the software package.
Structure Determination
Structure solution by X-ray crystallography is described in full in the Supple-
mental Experimental Procedures. In brief, equimolar amounts of D1, PN2-3,
and subtilisin-treated tubulin were mixed and the PN2-3-tubulin-D1 complex
was concentrated to 20 mg/ml. PN2-3-tubulin-D1 samples were comple-
mented with 0.2 mM GDP, 1 mM colchicine, and 5 mM DTT before setting
up sitting-drop vapor diffusion crystallization trials. Crystals were obtained in
a condition containing 20% polyethylene glycol (PEG) 550 monomethyl ether
and 0.1 M 2-(N-morpholino)ethanesulfonic acid (pH 6.5). X-Ray diffraction
data were collected at 100 K at beamline X06DA at the Swiss Light Source.
The PN2-3-tubulin-D1 structure was solved by molecular replacement using
the ab-tubulin-D1 complex structure as a search model (PDB: 4DRX). Data
collection and refinement statistics are given in Table S2.
In Vitro Reconstitution Assays
Protein purification for in vitro reconstitution assays is described in full in
Supplemental Experimental Procedures. Reconstitution of microtubule
growth dynamics in vitro was performed as described previously (Montenegro
Gouveia et al., 2010). In brief, flow chambers were functionalized by sequential
incubation with 0.2 mg/ml PLL-PEG-biotin (Susos) and 1 mg/ml NeutrAvidin
(Invitrogen) in MRB80 buffer (80 mM piperazine-N,N0-bis(2-ethanesulfonic
acid) [pH 6.8] supplemented with 4 mM MgCl2 and 1 mM EGTA). GMPCPP-
microtubule seeds were attached to coverslips through biotin-NeutrAvidin in-
teractions. The reaction mix with or without CPAPmini proteins (MRB80 buffer
supplemented with 15 mM tubulin, 0.5 mM rhodamine-tubulin, 50 mM KCl,
1 mM guanosine triphosphate, 0.2 mg/ml k-casein, 0.1% methylcellulose,
and oxygen scavenger mix [50 mM glucose, 400 mg/ml glucose oxidase,
200 mg/ml catalase, and 4 mM DTT]) was added to the flow chamber. Flow
chambers were sealed and dynamic microtubules were imaged immediately
at 30C using TIRF microscopy. Intensity analysis for CPAPmini along microtu-
bules, single-molecule fluorescence intensity analysis of CPAPmini, CPAPmini
molecule counting at microtubule tips, analysis of microtubule plus-end dy-
namics, and statistical analysis procedures are all described in full in Supple-
mental Experimental Procedures.
Immunofluorescence, Antibodies, and Microscopy
Cells were grown on glass coverslips and fixed in methanol for 7min at20C.
Cold treatment was carried out by incubating cells in ice-cold PBS, on ice, for
1 hr before fixation. Cells were permeabilized using 0.2%Triton X-100, washed
in PBS and 0.01% Triton X-100, and blocked for 1 hr in PBS, 1%BSA, and 2%374 Developmental Cell 37, 362–376, May 23, 2016fetal calf serum. All antibodies were diluted in the blocking solution and incu-
bated for either 1 hr at room temperature or 12 hr at 4C. Primary antibodies
were mouse anti-a-tubulin (DM1a, Sigma), mouse ‘‘20H5’’ anti-centrin-2 (a gift
from J. Salisbury), rabbit anti-hPOC5 (Azimzadeh et al., 2009; a gift from
M. Bornens), rabbit anti-CEP63 (Millipore 06-1292), goat anti-GFP (Abcam
ab6673), and rabbit anti-GFP (a gift from V. Simanis). Secondary antibodies
were goat anti-rabbit Alexa Fluor 488, goat anti-mouse Alexa Fluor 568,
donkey anti-goat Alexa Fluor 488, donkey anti-mouse Alexa Fluor 568, and
donkey anti-rabbit Alexa Fluor 647 (Invitrogen). All primary antibodies were
diluted 1,000-fold, except Centrin 2 (20003) and anti-a-tubulin (50003). All
secondary antibodies were diluted 1,000-fold. Samples were washed three
times between, and after, antibody incubations and incubated with 1 mg/ml
Hoechst in PBS prior to mounting in PBS, 90% glycerol, and 4% N-propyl
gallate.
Confocal imaging was carried out using a Zeiss LSM 700 microscope with a
Plan-Apochromat 633 oil-immersion objective, NA 1.40. Z sections were
imaged at an interval of 0.2 mm. All images shown are maximum-intensity
projections and were processed using Fiji (Schindelin et al., 2012), maintaining
relative intensities within a series.
Correlative Light and Electron Microscopy
CLEM is described in full in Supplemental Experimental Procedures. In brief,
endogenous CPAP was depleted by RNAi for 72 hr, simultaneous with induc-
tion of the transgene. For dual marker experiments, cells were transfected with
a tagRFP-Centrin 1 expression vector 16 hr prior to fixation. Cells were fixed,
then washed thoroughly with 0.1 M cacodylate buffer (pH 7.4), and imaged by
light microscopy. Immediately afterward, samples were post-fixed for 40 min
in 1.0% osmium tetroxide, then 30 min in 1.0% uranyl acetate in water, before
being dehydrated through increasing concentrations of alcohol and then
embedded in Durcupan ACM resin (Fluka). The coverslips were then placed
face down on a glass slide coated with mold-releasing agent (Glorex), with
approximately 1 mm of resin separating the two. These regions were mounted
on blank resin blocks with acrylic glue and trimmed with glass knives to form a
block ready for serial sectioning. Series of between 150 and 300 thin sections
(50 nm thickness) were cut with a diamond knife mounted on an ultramicro-
tome (Leica UC7). These sections were contrasted with lead citrate and uranyl
acetate and images taken using an FEI Spirit transmission electron micro-
scope equipped with an Eagle CCD camera.
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